Chinese Journal of Tissue Engineering Research ›› 2025, Vol. 29 ›› Issue (1): 52-57.doi: 10.12307/2024.731

Previous Articles     Next Articles

Baicalein mitigates ferroptosis of neurons after subarachnoid hemorrhage

Zhu Ting1, Yue Tingting2, Cui Yue1, Lu Yue2, Li Wei1, 2, Hang Chunhua1, 2   

  1. 1Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, Jiangsu Province, China; 2Department of Neurosurgery, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, Jiangsu Province, China
  • Received:2023-09-04 Accepted:2023-11-17 Online:2025-01-08 Published:2024-05-18
  • Contact: Hang Chunhua, MD, Chief physician, Professor, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, Jiangsu Province, China; Department of Neurosurgery, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, Jiangsu Province, China
  • About author:Zhu Ting, Master candidate, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, Jiangsu Province, China
  • Supported by:
    National Natural Science Foundation of China, No. 82130037, 81971122 (to HCH)

Abstract:

BACKGROUND: Ferroptosis is a mode of programmed cell death distinct from apoptosis, necrosis, and other novel cellular deaths, which occurs mainly due to accumulated lipid peroxidation. Ferroptosis has been shown to be involved in the pathological process following subarachnoid hemorrhage. Baicalein, serving as an adept sequestered of iron, evinces its prowess by quelling lipid peroxidative cascades. Nonetheless, the enigma lingers as to whether baicalein possesses the capacity to ameliorate neuronal ferroptosis, elicited in the wake of early brain injury after subarachnoid hemorrhage.

OBJECTIVE: To investigate the effect and mechanism of baicalein on neuronal ferroptosis after subarachnoid hemorrhage.

METHODS: Primary neuronal cells were extracted from C57BL/6L fetal mice at 16-17 days of gestation. Hemoglobin was used to stimulate primary neuronal cells to simulate an in vitro subarachnoid hemorrhage model. The viability of primary neuronal cells treated with baicalein at concentrations of 5, 15, 25, 50, and 100 μmol/L for 24 hours was detected by CCK-8 assay to determine the optimal concentration of baicalein. Primary neuronal cells were divided into control group, hemoglobin group, and hemoglobin+baicalein group. The levels of reactive oxygen species and malondialdehyde in cells were detected by kits. The mRNA expressions of ferroptosis-related markers PTGS2, SLC7A11, and glutathione peroxidase 4 were detected by RT-PCR. The primary neuronal cells were further divided into control group, SLC7A11 inhibitor Erastin group, hemoglobin group, hemoglobin+baicalein group, and hemoglobin+baicalein+Erastin group. The expression of the ferroptosis related markers SLC7A11 and glutathione peroxidase 4 was detected by western blot assay. 
RESULTS AND CONCLUSION: (1) Baicalein (25 μmol/L) was selected as the following experimental concentration. (2) Compared with the hemoglobin group, the level of malondialdehyde and the level of reactive oxygen species were significantly decreased (P < 0.05) in the hemoglobin+baicalein group. (3) Compared with the hemoglobin group, the mRNA expression of PTGS2 significantly decreased, and the mRNA expression of SLC7A11 and glutathione peroxidase 4 significantly increased (P < 0.000 1) in the hemoglobin+baicalein group. (4) SLC7A11 inhibitor Erastin could reverse the baicalin-improved ferroptosis effect to a certain extent (P < 0.05). (5) The results showed that baicalein could alleviate the ferroptosis of neuronal cells after subarachnoid hemorrhage through the SLC7A11/GPX4 pathway.

Key words: subarachnoid hemorrhage, baicalein, ferroptosis, neuron, Erastin, mouse

CLC Number: